The 2014 Expoquimia prize in the category of Biotechnology has been awarded to Iproteos for the research on "IPR19: a new drug for the treatment of the cognitive impairment associated with schizophrenia". Teresa Tarragó and Ernest Giralt, founders of Iproteos, received the prize from Luís Serrano, FEIQUE and Expoquimia President. The award recognises the biotechnological research on an original product or technology, with proven efficiency and in advanced stage for marketing. The 2014 Biotechnology R+D+i Award was organized by Expoquimia, the International Chemical Industry Show in an effort to combine forces in the chemical field and promote research. The award ceremony took place on 2nd of October at the "Fira Barcelona" and was included in the "World Chemical Summit" night event, that combined talks of the authorities with fancy and spectacular experiments. More information at the Expoquimia page.
Iproteos founders, Ernest Giralt and Teresa Tarragó, with the trophy of the R+D+i award